Current Pharmaceutical Design
-
Publication Venue For
- Stroke after Thoracic Endovascular Aortic Aneurysm Repair: A Silent Enemy that Needs More Caution.. 28:798-799. 2022
- Rivaroxaban versus Clopidogrel for Peripheral Artery Disease: A Clinico-Economic Approach of the COMPASS Trial.. 24:4516-4517. 2018
- Modular nanotransporters for targeted intracellular delivery of drugs: Folate receptors as potential targets. 21:1227-1238. 2015
- Taxation as prevention and as a treatment for obesity: the case of sugar-sweetened beverages.. 17:1218-1222. 2011
- Pipeline pharmacogenetics: a novel approach to integrating pharmaco-genetics into drug development.. 15:3754-3763. 2009
- Clopidogrel resistance: implications for coronary stenting.. 12:1261-1269. 2006
- The role of electrospinning in the emerging field of nanomedicine.. 12:4751-4770. 2006
- Treatment of PSA only recurrence of prostate cancer after prior local therapy.. 12:785-798. 2006
- VEGF inhibitors in cancer therapy.. 12:387-394. 2006
- GP IIb/IIIa blockade in elective percutaneous coronary intervention.. 10:387-398. 2004
- Imaging drug resistance with radiolabeled molecules.. 10:2965-2979. 2004
- Potential drug targets on the HIV-1 envelope glycoproteins, gp120 and gp41.. 9:1453-1462. 2003
- Astatine-211-labeled radiotherapeutics: an emerging approach to targeted alpha-particle radiotherapy.. 6:1433-1455. 2000
- Dosimetry and microdosimetry of targeted radiotherapy.. 6:1469-1502. 2000